Everlab raises AU$65m to turn primary care from treatment to prevention
Everlab raises AU$65m to turn primary care from treatment to prevention

The Melbourne healthtech’s oversubscribed Series A, led by Airtree, funds a move into the UK and a pitch to coordinate a patient’s health data over a lifetime rather than a single appointment. Most healthcare systems are built to wait. They are organis…

Meta is giving free AI glasses to every blind veteran in America
Meta is giving free AI glasses to every blind veteran in America

Meta is giving free Meta AI glasses to every blind veteran in America. Mark Zuckerberg announced the programme on Friday, offering a pair of Ray-Ban Meta glasses, at no cost, to all legally blind US veterans. “Meta AI on these glasses can describe what…

Thena Capital closes a £45M fund to back UK medtech, a first for an all-female GP team
Thena Capital closes a £45M fund to back UK medtech, a first for an all-female GP team

Thena Capital has closed its first fund at £45m ($60.4m), the London venture firm announced this week, after a £27m first close in March 2025. The fund backs early-stage British medical-technology companies, and it is now fully closed. The milestone is…

01Health raises £11.2M to turn its dental-AI platform into infrastructure for specialist care
01Health raises £11.2M to turn its dental-AI platform into infrastructure for specialist care

01Health, a London healthtech company, has raised £11.2M ($15M) in Series A funding to open up the clinical platform behind its dental brands and sell it to other practices. The round was led by Gresham House Ventures. Existing backers Balderton Capita…

Uncovr raises $7M for AI that writes the operative report before the surgeon leaves the room
Uncovr raises $7M for AI that writes the operative report before the surgeon leaves the room

Uncovr, a surgical AI startup based in New York and Paris, has raised $7M in seed funding to turn the video from an operation into its official written record. The round was led by Index Ventures. Seedcamp, Frst, No Label Ventures, and Entrepreneurs Fi…

The UK is reviewing its £330M NHS deal with Palantir, and may pull the plug in 2027
The UK is reviewing its £330M NHS deal with Palantir, and may pull the plug in 2027

The British government has put its most contentious health-tech contract on notice. It is now formally reviewing the NHS’s £330mn deal with Palantir, and weighing whether to walk away in 2027. Technology minister Liz Kendall confirmed the review this w…

A UK firm trained a “sovereign” NHS triage AI that it says rivals Claude, at a fraction of the cost
A UK firm trained a “sovereign” NHS triage AI that it says rivals Claude, at a fraction of the cost

The NHS does not lack for AI pitches. What it has lacked is one that keeps patient data inside the country. A British software firm says it now has it. OneAdvanced, the Birmingham-based SaaS company whose software touches more than 40 million NHS patie…

China just approved the world’s first commercial brain implant. The race with Neuralink is no longer theoretical.
China just approved the world’s first commercial brain implant. The race with Neuralink is no longer theoretical.

Controlling a machine with your mind used to be science fiction. Now it is a regulated medical product, at least in China. Earlier this year, China’s National Medical Products Administration approved NEO, a coin-sized brain-computer interface developed…

Healthcare’s $97bn staffing problem just won an AI training startup a $55M round
Healthcare’s $97bn staffing problem just won an AI training startup a $55M round

America’s hospitals are spending around $97bn a year renting staff they cannot train fast enough. Stepful thinks AI can fix the supply side, and investors have just handed it $55mn to try. The New York startup has raised a Series C led by healthcare-an…

Reid Hoffman leaves Microsoft’s board to go ‘founder mode’ with AI drug startup Manus
Reid Hoffman leaves Microsoft’s board to go ‘founder mode’ with AI drug startup Manus

Reid Hoffman is stepping down from Microsoft‘s board of directors after nearly a decade. The company disclosed the departure in a regulatory filing on Thursday. Hoffman said he wants to go “founder mode” with Manus, his AI-powered drug discovery startu…